Hematology Analyzers Market Report 2026

Hematology Analyzers Market Overview

• Hematology Analyzers market size has reached to $4.05 billion in 2025 • Expected to grow to $5.66 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Rising Incidence Of Blood Disorders Fueling The Growth Of The Market Due To Increasing Chronic Diseases • Market Trend: Technologically Advanced Platforms Improve Laboratory Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hematology Analyzers Market?

Hematology analyzers are automated laboratory instruments used to count and characterize blood cells, including red cells, white cells, and platelets. They are used in diagnosing and monitoring conditions such as anemia, infections, clotting disorders, and blood cancers. The main purpose of these analyzers is to provide accurate, rapid, and comprehensive blood test results to support clinical decision-making. The main types of hematology analyzers are fully automated hematology analyzers and semi-automated hematology analyzers. Fully automated hematology analyzers are advanced laboratory instruments designed to perform comprehensive blood analyses with minimal human intervention. These systems automate the entire testing process, including sample preparation, cell counting, and result interpretation. Various components, such as instruments, reagents, and consumables, are available in two primary modalities standalone and point-of-care. These devices utilize advanced technologies such as flow cytometry, electrical impedance, and optical technology, catering to end users such as hospitals, clinical laboratories, research institutions, and others.

What Is The Hematology Analyzers Market Growth Forecast?

The hematology analyzers market size is expected to see strong growth in the next few years. It will grow to $5.66 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for rapid diagnostics, increasing decentralization of laboratory testing, expansion of oncology and hematology diagnostics, growing adoption of digital pathology integration, increased focus on workflow automation. Major trends in the forecast period include increasing deployment of fully automated analyzers, rising integration of AI-assisted cell analysis, growing demand for point-of-care hematology testing, expansion of high-throughput laboratory systems, enhanced focus on diagnostic accuracy and speed.

Global Hematology Analyzers Market Segmentation

1) By Type: Fully-Automated Hematology Analyzers, Semi-Automated Hematology Analyzers 2) By Component: Instruments, Consumables 3) By Modality: Standalone, Point Of Care 4) By Technology: Flow Cytometry, Electrical Impedance, Optical Technology 5) By End User: Hospitals, Clinical Laboratories, Research Institutes, Other End Users Subsegments: 1) By Fully-Automated Hematology Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems 2) By Semi-Automated Hematology Analyzers: Hemoglobin Analyzers, Coagulation Analyzers, Erythrocyte Sedimentation Rate (ESR) Analyzers, Platelet Function Analyzers

What Is The Driver Of The Hematology Analyzers Market?

The rising incidence of blood disorders is expected to propel the growth of the hematology analyzers market going forward. Blood disorders refer to conditions that affect the components of blood, including red blood cells, white blood cells, platelets, or plasma. The increasing incidence of blood disorders is primarily due to the rising prevalence of chronic diseases, which directly impact blood health and require ongoing monitoring. Hematology analyzers aid in diagnosing blood disorders by providing accurate and rapid analysis of blood components, enabling timely detection and treatment. They enhance clinical decision-making, improving patient care and outcomes. For instance, in March 2024, according to the National Institute for Health and Care Excellence, a UK-based non-departmental public body, in 2022/2023, there were 2,069 individuals in the UK diagnosed with haemophilia B, including 374 with severe disease and 351 with moderate disease. Therefore, the rising incidence of blood disorders is driving the growth of the hematology analyzers industry.

Key Players In The Global Hematology Analyzers Market

Major companies operating in the hematology analyzers market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, Horiba Medical Ltd., Nihon Kohden Corporation, Trivitron Healthcare Pvt. Ltd., Transasia Bio-Medicals Ltd., Erba Mannheim GmbH, Boule Diagnostics AB, Diatron MI PLC, Rayto Life and Analytical Sciences Co. Ltd., Perlong Medical, PZ Cormay S.A., Bio-Rad Laboratories Inc., BioSystems, EKF Diagnostics, Ortho Clinical Diagnostics, URIT Medical Electronic Group, Agappe Diagnostics

Global Hematology Analyzers Market Trends and Insights

Major companies operating in the hematology analyzers market are focusing on developing technologically advanced products, such as automated hematology systems, to improve diagnostic accuracy, enhance workflow efficiency, and deliver faster test results with minimal manual intervention. Automated hematology systems refer to advanced diagnostic machines used in clinical laboratories to perform a variety of hematological tests with minimal manual intervention. For instance, in January 2024, Horiba Medical, a Japan-based medical diagnostics company, launched the HELO 2.0 high-throughput automated hematology platform, Conformité Européenne In Vitro Diagnostic Regulation (CE-IVDR) approved, with pending United States Food and Drug Administration (FDA) approval. HELO 2.0 offers a flexible, scalable, and efficient modular solution designed to meet the needs of mid- to large-scale laboratories. It also features advanced technologies from the Yumizen H2500 and H1500 analyzers, ensuring high-quality performance with 360-degree sample mixing, optimized turnaround time, space utilization, and reagent storage. It also supports ISO-15189 accreditation assistance, addressing all pre-, post-, and analytical needs.

What Are Latest Mergers And Acquisitions In The Hematology Analyzers Market?

In June 2023, Mars Incorporated, a US-based food company, acquired Heska Corporation for $1.3 billion. With this acquisition, Mars aims to expand its presence in the animal health diagnostics sector, particularly in veterinary diagnostics, and further enhance its comprehensive suite of diagnostic solutions for veterinary professionals. Heska Corporation is a US-based veterinary diagnostics company specializing in veterinary diagnostics, including hematology analyzers.

Regional Outlook

North America was the largest region in the hematology analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hematology Analyzers Market?

The hematology analyzers market consists of sales of electrolyte analyzers, microplate readers, and diagnostic blood testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hematology Analyzers Market Report 2026?

The hematology analyzers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hematology analyzers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.